Melanoma Antigens Recognized by T Lymphocytes-Reference-Cited by-同舟云学术

Melanoma Antigens Recognized by T Lymphocytes

Published:2011-11-13 Issue: Volume: Page:187-205
ISSN:
Container-title:Targeted Therapeutics in Melanoma
language:
Short-container-title:

Author:

van Baren Nicolas,Baurain Jean-François,Brasseur Francis,Coulie Pierre G.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-61779-407-0_11

Reference100 articles.

1. Oble DA, Loewe R, Yu P, Mihm Jr MC. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun. 2009;9:3.

2. Morton DL, Eilber FR, Holmes EC, et al. BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg. 1971;180:635–43.

3. Rosenberg SA, Lotze MT, Yang JC, et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst. 1993;85:622–32.

4. Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol. 1999;17:2105–16.

5. Petrella T, Quirt I, Verma S, Haynes AE, Charette M, Bak K. Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review. Cancer Treat Rev. 2007;33:484–96.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of pathogenic genes and transcription factors in vitiligo;Dermatologic Therapy;2019-08-28

2. Human Tumor Antigens and Cancer Immunotherapy;BioMed Research International;2015

3. Human cancer regression antigens;Current Opinion in Immunology;2013-04